Work

579 Rationale and design for the Kallikrein Inhibitor in Netherton Syndrome (KINS) pivotal clinical trial

Year: 2020

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2020.03.589

Authors: K.W. Johnson, A. Hovnanian, J. Teng, A.S. Paller, K. Choate, P. Elias, Z. Laura, T. Nguyen, D. Smith, A. Hsu, L. Alani, C. Lai, L. Hsu

Institutions: Inserm, Stanford University, Northwestern University, Yale University, University of California, San Francisco

Language: English

Topic: Skin and Cellular Biology Research

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3036557626

FWCI:

Cites:

Cited by:

Related to: 10